Finance experts mixed on prospects of marijuana capital infusion
Reaching consensus on hotly debated issues is rare in the cannabis space, especially when it comes to potential ramifications of marijuana rescheduling. Some industry experts, such as cannabis hedge fund manager Patrick Rea, are optimistic that a wall of capital will flow into the sector, given the right catalyst. Others, including banker Peter Su, remain […]
Navigating the Double-Edged Sword of Federal Cannabis Legalization – Cannabis Business Executive – Cannabis and Marijuana industry news
Navigating the Double-Edged Sword of Federal Cannabis Legalization – Cannabis Business Executive – Cannabis and Marijuana industry news skip to Main Content Source link
25 participants tapped for DEA’s marijuana rescheduling hearing
The U.S. Drug Enforcement Administration has contacted 25 “designated participants” to testify at a Dec. 2 hearing about marijuana rescheduling, according to documents obtained by MJBizDaily. Before marijuana can be moved from Schedule 1 to Schedule 3 of the Controlled Substances Act, DEA Administrator Anne Milgram ordered that the matter go before an administrative law judge. […]
Tax policies compound headaches for state-legal cannabis operators beyond 280E
The Internal Revenue Service continues to be a thorn in the side of state-legal marijuana businesses, even as their hemp industry cousins largely dodge the taxman’s scrutiny, creating an increasingly lopsided playing field. “Hemp is not subject to 280E, or is at least reasonably interpreted as not being subject to 280E, even if you’re selling […]
Accounting group pushes for clarity as questions around cannabis tax rules mount
The Internal Revenue Service faces mounting pressure to clarify cannabis tax rules, as a key Supreme Court decision threatens to upend the agency’s interpretative authority and rescheduling looms large over the industry. The American Institute of CPAs in a letter this week urged the U.S. Treasury Department and the IRS to provide advance guidance for […]